Clinical Trials Directory

Trials / Completed

CompletedNCT01602081

Ligation of the Intersphincteric Fistula Tract (LIFT) + Biodesign for Anal Fistula

Ligation of the Intersphincteric Fistula Tract With Tissue Graft Placement for Treatment of Persistent Trans-sphincteric Anal Fistula

Status
Completed
Phase
Study type
Observational
Enrollment
28 (actual)
Sponsor
Cook Group Incorporated · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The LIFT+Biodesign® study is a post-market observational study to evaluate the rate of fistula closure in patients with persistent trans-sphincteric anal fistula who receive the Biodesign® Tissue graft as part of their LIFT procedure.

Conditions

Interventions

TypeNameDescription
DEVICEreinforce soft tissuereinforce soft tissue

Timeline

Start date
2013-01-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2012-05-18
Last updated
2015-02-11

Locations

8 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01602081. Inclusion in this directory is not an endorsement.

Ligation of the Intersphincteric Fistula Tract (LIFT) + Biodesign for Anal Fistula (NCT01602081) · Clinical Trials Directory